Skip to content
  • About Us
  • Alzheimer’s Disease
    • Current Treatments
    • Our approach: ALPHA-1062
  • ALS
    • Our approach: ALPHA-602
  • Our Patents
  • Our Pipeline
  • News
  • Contact Us

News

December 9, 2020
ACI Announces Granted JPN Patent for Alpha-1062
June 8, 2020
ACI Attends the 2020 BIO Digital Partnering Conference
May 13, 2020
Business TV: Alzheimer’s Treatment with Minimal Side Effects
May 12, 2020
ACI Announces Granted EU Patents and Orphan Drug Designation for its Progranulin Platform
April 30, 2020
Alpha Cognition Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer’s Therapy
April 21, 2020
Linical and Alpha Cognition Announce Strategic Partnership
April 09, 2020
Alpha Cognition Inc. Announces its Name Change

Copyright © AlphaCognition Inc. 2019

About Us

Alzheimer's disease

  • Current Treatments
  • Our approach: ALPHA-1062

ALS

  • Our approach: ALPHA-602

Our Patents

Our Pipeline

Contact Us